Sygnature Discovery offers a fully validated panel of electrophysiology assays spanning the KV1.x subfamily. Using automated electrophysiology platforms, each isoform was profiled to define its unique activation and inactivation kinetics, alongside pharmacological...
Advancing Kv2.2 Drug Discovery Sygnature Discovery's ion channel screening platform provides reliable, high-quality data to support the search of novel starting points for Kv2.2 drug discovery. By integrating well-characterized cellular models with high-throughput...
BK channel screening allows investigation of the functional and pharmacological impact of β-subunit expression using electrophysiology. Sygnature Discovery provides detailed profiling to support BK channel-focussed drug discovery and lead optimization. Introduction BK...